Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy

Non-small cell lung cancer (NSCLC) remains the most common cause of cancer-related mortality. The heterogeneous nature of this disease hinders its diagnosis and treatment, requiring continuous advances in research aiming to understand its intricate nature. Consequently, the retrospective analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Fernández, Coral, Fornaguera, Cristina, Borrós, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352459/
https://www.ncbi.nlm.nih.gov/pubmed/32570729
http://dx.doi.org/10.3390/cancers12061609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352459/
https://www.ncbi.nlm.nih.gov/pubmed/32570729
http://dx.doi.org/10.3390/cancers12061609

Ejemplares similares